Neuropeptide FF activates ERK and NF kappa B signal pathways in differentiated SH-SY5Y cells

Peptides

Volumn 38, Issue 1, 2012, Pages 110-117

  Sun, Yu Long ^a   Zhang, Xiao Yuan ^a   He, Ning ^a   Sun, Tao ^a   Zhuang, Yan ^a   Fang, Quan ^a   Wang, Kai Rong ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

ERK; Neuropeptide FF; NF kappa B; Nitric oxide synthase; NPFF2 receptor; SH SY5Y

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUROPEPTIDE FF; NITRIC OXIDE SYNTHASE;

ARTICLE; CELL DIFFERENTIATION; DOWN REGULATION; ENZYME ACTIVATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; ISOQUINOLINES; NF-KAPPA B; NITRIC OXIDE; OLIGOPEPTIDES; PROTEIN KINASE INHIBITORS; RECEPTORS, NEUROPEPTIDE; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 84866292334     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.08.019     Document Type: Article

References (90)

1. M. Allard, S. Labrouche, A. Nosjean, and R. Laguzzi Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat J Pharmacol Exp Ther 274 1995 577 583
2. N. Altier, A. Dray, D. Menard, and J.L. Henry Neuropeptide FF attenuates allodynia in models of chronic inflammation and neuropathy following intrathecal or intracerebroventricular administration Eur J Pharmacol 407 2000 245 255
3. M.L. Anko, and P. Panula Regulation of endogenous human NPFF2 receptor by neuropeptide FF in SK-N-MC neuroblastoma cell line J Neurochem 96 2006 573 584
4. Y. Ben-Neriah, and M. Karin Inflammation meets cancer, with NF-kappaB as the matchmaker Nat Immunol 12 2011 715 723
5. J.L. Biedler, L. Helson, and B.A. Spengler Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture Cancer Res 33 1973 2643 2652
6. J.A. Bonini, K.A. Jones, N. Adham, C. Forray, R. Artymyshyn, and M.M. Durkin Identification and characterization of two G protein-coupled receptors for neuropeptide FF J Biol Chem 275 2000 39324 39331
7. G. Bonizzi, M. Bebien, D.C. Otero, K.E. Johnson-Vroom, Y. Cao, and D. Vu Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers EMBO J 23 2004 4202 4210
8. T. Boutros, E. Chevet, and P. Metrakos Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer Pharmacol Rev 60 2008 261 310
9. A. Caraty, M. Blomenrohr, G.M. Vogel, D. Lomet, C. Briant, and M. Beltramo RF9 powerfully stimulates gonadotrophin secretion in the ewe: evidence for a seasonal threshold of sensitivity J Neuroendocrinol 24 2012 725 736
10. M. Cargnello, and P.P. Roux Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases Microbiol Mol Biol Rev 75 2011 50 83
11. J.C. Chen, W.H. Lee, P.C. Chen, C.P. Tseng, and E.Y. Huang Rat NPFF(1) receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide Peptides 27 2006 1005 1014
12. J. Chiaravalli, E. Fontan, H. Fsihi, Y.M. Coic, F. Baleux, and M. Veron Direct inhibition of NF-kappaB activation by peptide targeting the NOA ubiquitin binding domain of NEMO Biochem Pharmacol 82 2011 1163 1174
13. E.G. de Mejia, and V.P. Dia Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappaB pathway in the macrophage Peptides 30 2009 2388 2398
14. B. Decker, B. Vadokas, U. Kutschenreuter, K. Golenhofen, K. Voigt, and G.P. McGregor Action of FMRFamide-like peptides on porcine gastrointestinal motility in vitro Peptides 18 1997 1531 1537
15. F. Denizot, and R. Lang Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability J Immunol Methods 89 1986 271 277
16. C. Desprat, and J.M. Zajac Hypothermic effects of neuropeptide FF analogues in mice Pharmacol Biochem Behav 58 1997 559 563
17. A.S. Dhillon, S. Hagan, O. Rath, and W. Kolch MAP kinase signalling pathways in cancer Oncogene 26 2007 3279 3290
18. A.H. Ding, C.F. Nathan, and D.J. Stuehr Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production J Immunol 141 1988 2407 2412
19. G.J. Dockray The expanding family of -RFamide peptides and their effects on feeding behaviour Exp Physiol 89 2004 229 235
20. K. Elhabazi, J.M. Trigo, C. Mollereau, L. Mouledous, J.M. Zajac, and F. Bihel Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments Br J Pharmacol 165 2012 424 435
21. N.A. Elshourbagy, R.S. Ames, L.R. Fitzgerald, J.J. Foley, J.K. Chambers, and P.G. Szekeres Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor J Biol Chem 275 2000 25965 25971
22. Q. Fang, J. Guo, M. Chang, L.X. Chen, Q. Chen, and R. Wang Neuropeptide FF receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon Peptides 26 2005 791 797
23. Q. Fang, Z.L. Han, N. Li, Z.L. Wang, N. He, and R. Wang Effects of neuropeptide FF system on CB(1) and CB(2) receptors mediated antinociception in mice Neuropharmacology 62 2012 855 864
24. Q. Fang, N. Li, T.N. Jiang, Q. Liu, Y.L. Li, and R. Wang Pressor and tachycardic responses to intrathecal administration of neuropeptide FF in anesthetized rats Peptides 31 2010 683 688
25. Q. Fang, Y.Q. Wang, F. He, J. Guo, Q. Chen, and R. Wang Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist Regul Pept 147 2008 45 51
26. H.C. Fehmann, G. McGregor, V. Weber, R. Eissele, R. Goke, and B. Goke The effects of two FMRFamide related peptides (A-18-F-amide and F-8-F-amide; 'morphine modulating peptides') on the endocrine and exocrine rat pancreas Neuropeptides 17 1990 87 92
27. S. Fukusumi, R. Fujii, and S. Hinuma Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP Peptides 27 2006 1073 1086
28. S. Gicquel, J. Fioramonti, L. Bueno, and J.M. Zajac Effects of F8Famide analogs on intestinal transit in mice Peptides 14 1993 749 753
29. V.D. Goncharuk, R.M. Buijs, J.H. Jhamandas, and D.F. Swaab Vasopressin (VP) and neuropeptide FF (NPFF) systems in the normal and hypertensive human brainstem J Comp Neurol 519 2011 93 124
30. C. Gouarderes, M. Sutak, J.M. Zajac, and K. Jhamandas Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat Eur J Pharmacol 237 1993 73 81
31. M. Gyrd-Hansen, and P. Meier IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer Nat Rev Cancer 10 2010 561 574
32. M.S. Hayden, and S. Ghosh Shared principles in NF-kappaB signaling Cell 132 2008 344 362
33. S. Hinuma, Y. Shintani, S. Fukusumi, N. Iijima, Y. Matsumoto, and M. Hosoya New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals Nat Cell Biol 2 2000 703 708
34. E.Y. Huang, J.Y. Li, P.P. Tan, C.H. Wong, and J.C. Chen The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF) Peptides 21 2000 205 210
35. J.H. Jhamandas, and D. Mactavish Central administration of neuropeptide FF (NPFF) causes increased neuronal activation and up-regulation of NPFF gene expression in the rat brainstem J Comp Neurol 447 2002 300 307
36. M.L. Kalliomaki, and P. Panula Neuropeptide FF, but not prolactin-releasing peptide, mRNA is differentially regulated in the hypothalamic and medullary neurons after salt loading Neuroscience 124 2004 81 87
37. S.M. Kazmi, and R.K. Mishra Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells Mol Pharmacol 32 1987 109 118
38. S.M. Kazmi, and R.K. Mishra Identification of alpha 2-adrenergic receptor sites in human retinoblastoma (Y-79) and neuroblastoma (SH-SY5Y) cells Biochem Biophys Res Commun 158 1989 921 928
39. V.K. Kontinen, A.A. Aarnisalo, J.J. Idanpaan-Heikkila, P. Panula, and E. Kalso Neuropeptide FF in the rat spinal cord during carrageenan inflammation Peptides 18 1997 287 292
40. M. Kotani, C. Mollereau, M. Detheux, E. Le Poul, S. Brezillon, and J. Vakili Functional characterization of a human receptor for neuropeptide FF and related peptides Br J Pharmacol 133 2001 138 144
41. S. Labrouche, J.P. Laulin, M. Le Moal, G. Tramu, and G. Simonnet Neuropeptide FF in the rat adrenal gland: presence, distribution and pharmacological effects J Neuroendocrinol 10 1998 559 565
42. R. Laguzzi, A. Nosjean, H. Mazarguil, and M. Allard Cardiovascular effects induced by the stimulation of neuropeptide FF receptors in the dorsal vagal complex: an autoradiographic and pharmacological study in the rat Brain Res 711 1996 193 202
43. J. Lameh, F. Bertozzi, N. Kelly, P.M. Jacobi, D. Nguyen, and A. Bajpai Neuropeptide FF receptors have opposing modulatory effects on nociception J Pharmacol Exp Ther 334 2010 244 254
44. P. Laurent, J.A. Becker, O. Valverde, C. Ledent, A. de Kerchove d'Exaerde, and S.N. Schiffmann The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10 Nat Neurosci 8 2005 1735 1741
45. B. Leader, Q.J. Baca, and D.E. Golan Protein therapeutics: a summary and pharmacological classification Nat Rev Drug Discov 7 2008 21 39
46. J.C. Lecron, M. Minault, M. Allard, P. Goube de Laforest, J. Gombert, and G. Simonnet Modulation of human lymphocyte proliferation by FLFQPQRFamide, a FMRFamide-like peptide with anti-opiate properties J Neuroimmunol 38 1992 1 8
47. I. Lefrere, P. De Coppet, J.C. Camelin, S. Le Lay, N. Mercier, and N. Elshourbagy Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsiveness J Biol Chem 277 2002 39169 39178
48. Q. Liu, X.M. Guan, W.J. Martin, T.P. McDonald, M.K. Clements, and Q. Jiang Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception J Biol Chem 276 2001 36961 36969
49. E.A. Majane, and H.Y. Yang FMRF-NH2-like peptide is deficient in the pituitary gland of the Brattleboro rat Peptides 11 1990 345 349
50. E.A. Majane, and H.Y. Yang Mammalian FMRF-NH2-like peptide in rat pituitary: decrease by osmotic stimulus Peptides 12 1991 1303 1308
51. D.H. Malin, J.R. Lake, J.A. Jones, J. Morel, W.D. Moon, and B.P. Corbit Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF Peptides 17 1996 615 618
52. P. Marini, A.S. Moriello, L. Cristino, M. Palmery, L. De Petrocellis, and V. Di Marzo Cannabinoid CB1 receptor elevation of intracellular calcium in neuroblastoma SH-SY5Y cells: interactions with muscarinic and delta-opioid receptors Biochim Biophys Acta 1793 2009 1289 1303
53. A. Martinez-Ruiz, S. Cadenas, and S. Lamas Nitric oxide signaling: classical, less classical, and nonclassical mechanisms Free Radic Biol Med 51 2011 17 29
54. C. McKeon, C.J. Thiele, R.A. Ross, M. Kwan, T.J. Triche, and J.S. Miser Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma Cancer Res 48 1988 4307 4311
55. M. Minault, J.C. Lecron, S. Labrouche, G. Simonnet, and J. Gombert Characterization of binding sites for neuropeptide FF on T lymphocytes of the Jurkat cell line Peptides 16 1995 105 111
56. C. Mollereau, H. Mazarguil, J.M. Zajac, and M. Roumy Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells Mol Pharmacol 67 2005 965 975
57. L. Mouledous, C. Froment, S. Dauvillier, O. Burlet-Schiltz, J.M. Zajac, and C. Mollereau GRK2 protein-mediated transphosphorylation contributes to loss of function of mu-opioid receptors induced by neuropeptide FF (NPFF2) receptors J Biol Chem 287 2012 12736 12749
58. L. Mouledous, C. Mollereau, and J.M. Zajac Opioid-modulating properties of the neuropeptide FF system Biofactors 36 2010 423 429
59. T. Murase, H. Arima, K. Kondo, and Y. Oiso Neuropeptide FF reduces food intake in rats Peptides 17 1996 353 354
60. D.M. Nicklous, and K.J. Simansky Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake Am J Physiol Regul Integr Comp Physiol 285 2003 R1046 R1054
61. A. Oeckinghaus, M.S. Hayden, and S. Ghosh Crosstalk in NF-[kappa]B signaling pathways Nat Immunol 12 2011 695 708
62. P. Panula, A.A. Aarnisalo, and K. Wasowicz Neuropeptide FF, a mammalian neuropeptide with multiple functions Prog Neurobiol 48 1996 461 487
63. P. Panula, E. Kalso, M. Nieminen, V.K. Kontinen, A. Brandt, and A. Pertovaara Neuropeptide FF and modulation of pain Brain Res 848 1999 191 196
64. M. Pasparakis Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases Nat Rev Immunol 9 2009 778 788
65. N.D. Perkins Integrating cell-signalling pathways with NF-kappaB and IKK function Nat Rev Mol Cell Biol 8 2007 49 62
66. N.D. Perkins The diverse and complex roles of NF-kappaB subunits in cancer Nat Rev Cancer 12 2012 121 132
67. S.J. Perry, E. Yi-Kung Huang, D. Cronk, J. Bagust, R. Sharma, and R.J. Walker A human gene encoding morphine modulating peptides related to NPFF and FMRFamide FEBS Lett 409 1997 426 430
68. M.M. Rahman, and G. McFadden Modulation of NF-kappaB signalling by microbial pathogens Nat Rev Microbiol 9 2011 291 306
69. R.A. Ross, B.A. Spengler, and J.L. Biedler Coordinate morphological and biochemical interconversion of human neuroblastoma cells J Natl Cancer Inst 71 1983 741 747
70. M. Roumy, C. Lorenzo, S. Mazeres, S. Bouchet, J.M. Zajac, and C. Mollereau Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity J Biol Chem 282 2007 8332 8342
71. M. Roumy, and J.M. Zajac Neuropeptide FF, pain and analgesia Eur J Pharmacol 345 1998 1 11
72. L. Rui, R. Schmitz, M. Ceribelli, and L.M. Staudt Malignant pirates of the immune system Nat Immunol 12 2011 933 940
73. J. Ruland Return to homeostasis: downregulation of NF-kappaB responses Nat Immunol 12 2011 709 714
74. T.H. Saito, R. Nakane, Y. Akazome, H. Abe, and Y. Oka Electrophysiological analysis of the inhibitory effects of FMRFamide-like peptides on the pacemaker activity of gonadotropin-releasing hormone neurons J Neurophysiol 104 2010 3518 3529
75. K. Schulte, M. Kumar, J.M. Zajac, and E. Schlicker Noradrenaline release in rodent tissues is inhibited by interleukin-1beta but is not affected by urotensin II, MCH, NPW and NPFF Pharmacol Rep 63 2011 102 111
76. S. Seino, and Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis Physiol Rev 85 2005 1303 1342
77. D.M. Sundblom, P. Heikman, H. Naukkarinen, and F. Fyhrquist Blood concentrations of vasopressin, neuropeptide FF and prolactin are increased by high-dose right unilateral ECT Peptides 20 1999 319 326
78. D. Sunter, A.K. Hewson, S. Lynam, and S.L. Dickson Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat Neurosci Lett 313 2001 145 148
79. K. Tasken, and E.M. Aandahl Localized effects of cAMP mediated by distinct routes of protein kinase A Physiol Rev 84 2004 137 167
80. I. Tegeder, R. Scheving, I. Wittig, and G. Geisslinger SNO-ing at the nociceptive synapse Pharmacol Rev 63 2011 366 389
81. S. Vallabhapurapu, and M. Karin Regulation and function of NF-kappaB transcription factors in the immune system Annu Rev Immunol 27 2009 693 733
82. P.F. Vaughan, C. Peers, and J.H. Walker The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release Gen Pharmacol 26 1995 1191 1201
83. F.S. Vilim, A.A. Aarnisalo, M.L. Nieminen, M. Lintunen, K. Karlstedt, and V.K. Kontinen Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli Mol Pharmacol 55 1999 804 811
84. E.F. Wagner, and A.R. Nebreda Signal integration by JNK and p38 MAPK pathways in cancer development Nat Rev Cancer 9 2009 537 549
85. Y.Q. Wang, S.B. Wang, J.L. Ma, J. Guo, Q. Fang, and T. Sun Neuropeptide FF receptor antagonist, RF9, attenuates the fever induced by central injection of LPS in mice Peptides 32 2011 702 706
86. H.Y. Yang, W. Fratta, E.A. Majane, and E. Costa Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine Proc Natl Acad Sci USA 82 1985 7757 7761
87. H.Y. Yang, and M.J. Iadarola Activation of spinal neuropeptide FF and the neuropeptide FF receptor 2 during inflammatory hyperalgesia in rats Neuroscience 118 2003 179 187
88. H.Y. Yang, T. Tao, and M.J. Iadarola Modulatory role of neuropeptide FF system in nociception and opiate analgesia Neuropeptides 42 2008 1 18
89. X. Yang, H. Jin, K. Liu, Q. Gu, and X. Xu A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway PLoS One 6 2011 e29155
90. J.M. Zajac, J.P. Latapie, and B. Frances Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia Peptides 21 2000 1209 1213